PREMIQUE Modified release tablet Ref.[27876] Active ingredients: Estrogens, conjugated Medroxyprogesterone

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Product name and form

Premique Low Dose 0.3mg/1.5mg modified release tablets.

Pharmaceutical Form

Modified release tablet.

Cream oval biconvex sugar coated tablet marked “PREMPRO 0.3/1.5” in black ink.

Qualitative and quantitative composition

Conjugated estrogens^†^ 0.3 mg and medroxyprogesterone acetate (MPA) 1.5 mg.

Conjugated estrogens contain the sodium sulfate conjugates of estrone, equilin, 17α-dihydroequilin, 17α-estradiol, 17β-dihydroequilin, 17α-dihydroequilenin, 17β-dihydroequilenin, equilenin, 17β-estradiol and Δ8,9-dehydro-estrone.

Excipients: contains 61.7mg of lactose monohydrate and 40.69mg of sucrose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Estrogens, conjugated

The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Medroxyprogesterone

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

List of Excipients

Tablet core:

Lactose Monohydrate
Microcrystalline Cellulose
Hypromellose 2208, K100M
Magnesium Stearate
Purified Water

Tablet coating:

Sucrose
Microcrystalline Cellulose
Hydroxypropyl Cellulose
Hypromellose, 2910, E6
Hypromellose, 2910, E15
Polyethylene Glycol 400
Purified Water
Eudragit NE 30 D (30% solids)
(Ethyl Acrylate and Methacrylate Copolymer Dispersion)
Spectrablend light Yellowa
Purified Water
Hypromellose 2910 E6
Carnauba Wax
Purified Water

Printing on tablet: Opacode WB NS-78-17821, Black Ink (Purified Water, Iron Oxide Black (E172), Isopropyl Alcohol, Propylene Glycol, Hypromellose 2910)

a Contains: Hypromellose 2910, Titanium Dioxide (E171) and Yellow Iron Oxide (E172)

Pack sizes and marketing

Blister pack, consisting of a polyvinyl chloride (PVC)/Aclar film and aluminum foil with heat seal coating containing 28 tablets. Each carton contains 28 tablets (1 blister pack) or 84 tablets (3 blister packs).

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/1288

14th September 2011

Drugs

Drug Countries
PREMIQUE Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.